UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 6-K

 

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934

 

May 3, 2007
Commission File Number: 333-142287

 


 

NXP B.V.

(Exact name of registrant as specified in charter)

 

The Netherlands

(Jurisdiction of  incorporation or organization)

 

60 High Tech Campus, 5656 AG, Eindhoven, The Netherlands

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F   x

 

Form 40-F   o

 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1).

 

Yes   o

 

No   x

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7).

 

Yes   o

 

No   x

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing

the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes   o

 

No   x

 

Name and address of person authorized to receive notices
and communications from the Securities and Exchange Commission

 

Dr. Jean A.W. Schreurs
60 High Tech Campus
5656 AG Eindhoven—The Netherlands

 

 




 

This report contains the quarterly report of NXP B.V. (the “Company”) for the three months ended March 31, 2007, as furnished to holders of the Company’s debt securities on May 3, 2007.  This report also contains a copy of the press release entitled “NXP announces launch of exchange offer for its Notes”, dated April 27, 2007, and of the press release entitled “NXP Semiconductors Announces First Quarter 2007 Results”, dated May 3, 2007.

 

Exhibits

 

 

 

 

 

 

 

 99.1

 

Quarterly Report of NXP Semiconductors Group

 

 

 

 99.2

 

Press release, dated April 27, 2007

 

 

 

 99.3

 

Press release, dated May 3, 2007

 




 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized at Eindhoven, on the 3rd day of May 2007.

 

NXP B.V.

 

 

/s/ Frans van Houten

 

Frans van Houten

(President and Chief Executive Officer, Chairman of the Board of Management)

 

 

/s/ Peter van Bommel

 

Peter van Bommel

(Chief Financial Officer, Member of the Board of Management)

 



Exhibit 99.1

Quarterly report of the NXP Group

 

for the 1st quarter ended March 31, 2007

 

Forward-looking statements

This document includes forward-looking statements. When used in this document, the words “anticipate,” “believe,” “estimate,” “forecast,” “expect,” “intend,” “plan” and “project,” and similar expressions, as they relate to us, our management or third parties, identify forward-looking statements. Forward-looking statements include statements regarding our business strategy, financial condition, results of operations, and market data, as well as any other statements which are not historical facts. These statements reflect beliefs of our management as well as assumptions made by our management and information currently available to us. Although we believe that these beliefs and assumptions are reasonable, the statements are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. These factors, risks and uncertainties expressly qualify all subsequent oral and written forward-looking statements attributable to us or persons acting on our behalf and include the following: market demand and semiconductor industry conditions, our ability to successfully introduce new technologies and products, the demand for the goods into which our products are incorporated, our ability to generate sufficient cash or raise sufficient capital to meet both our debt service and research and development and capital investment requirements, our ability to accurately estimate demand and match our production capacity accordingly or obtain supplies from third-party producers, our access to production from third-party outsourcing partners, and any events that might affect their business or our relationship with them, our ability to secure adequate and timely supply of equipment and materials from suppliers, our ability to avoid operational problems and product defects and, if such issues were to arise, to rectify them quickly, our ability to form strategic partnerships and joint ventures and successfully cooperate with our alliance partners, our ability to win competitive bid selection processes to develop products for use in our customers’ equipment and products, our ability to successfully establish a brand identity, our ability to successfully hire and retain key management and senior product architects; and, our ability to maintain good relationships with our suppliers.

Except for any ongoing obligation to disclose material information as required by the United States federal securities laws, we do not have any intention or obligation to update forward-looking statements after we distribute this document. In addition, this document contains information concerning the semiconductor industry, our market segments and business units generally, which is forward-looking in nature and is based on a variety of assumptions regarding the ways in which the semiconductor industry, our market segments and product areas will develop. We have based these assumptions on information currently available to us, if any one or more of these assumptions turn out to be incorrect, actual market results may differ from those predicted. While we do not know what impact any such differences may have on our business, if there are such differences, our future results of operations and financial condition, and the market price of the notes, could be materially adversely affected.

Use of non-US GAAP information

In presenting and discussing the NXP Group’s financial position, operating results and cash flows, management uses certain non-US GAAP financial measures. These non-US GAAP financial measures should not be viewed in isolation as alternatives to the equivalent US GAAP measure(s) and should be used in conjunction with the most directly comparable US GAAP measure(s). Aleft page discussion of the non-US GAAP measures included in this document and a reconciliation of such measures to the most directly comparable US GAAP measure(s) are contained in this document.

Use of fair value measurements

In presenting the NXP Group’s financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that we consider to be reliable. Users are cautioned that these values are subject to changes over time and are only valid the balance sheet date. When a readily determinable market value does not exist, we estimate fair values using valuation models which we believe are appropriate for their purpose. These require management to make significant assumptions with respect to future developments which are inherently uncertain and may therefore deviate from actual developments. In certain cases independent valuations are obtained to support management’s determination of fair values.




 

Table of Contents

 

Page

 

Introduction

 

3

 

 

 

 

 

Report on the performance of the NXP Group:

 

 

 

Group performance

 

4

 

Performance by Segment

 

7

 

Liquidity and Capital Resources

 

9

 

Subsequent Events

 

10

 

Outlook

 

10

 

 

 

 

 

Group Financial Statements:

 

 

 

Combined and Consolidated statements of operations

 

11

 

Combined and Consolidated balance sheets

 

12

 

Combined and Consolidated statements of cash flows

 

13

 

Consolidated statements of changes in shareholder’s equity and comprehensive income (loss)

 

14

 

Information by segments

 

15

 

Main countries

 

16

 

Reconciliation of non-US GAAP information

 

17

 

Supplemental Guarantor information

 

19

 

Quarterly statistics

 

22

 

 

2




Introduction

On September 29, 2006, Koninklijke Philips Electronics N.V. (“Philips”) sold 80.1% of its semiconductors businesses to a consortium of private equity investors (the “Private Equity Consortium”). These semiconductor businesses were transferred to NXP B.V. (“NXP” or the “Company”), a wholly-owned subsidiary of Philips, on September 28, 2006. All of NXP’s issued and outstanding shares were then acquired by KASLION Acquisition B.V. (“KASLION”), which was formed as an acquisition vehicle by the Private Equity Consortium and Philips. This transaction is referred to as the “Acquisition”. In order to fund the acquisition of NXP by KASLION, the Private Equity Consortium and Philips contributed cash to KASLION in exchange for 80.1% and 19.9%, respectively, of the total equity of KASLION.

As a result of the Acquisition, the financial statements are presented on a Predecessor and Successor basis: The predecessor periods reflect the combined financial results of NXP prior to the Acquisition. The successor periods reflect the consolidated financial results after the Acquisition. The Company also refers to the operations of NXP for both the predecessor and successor periods as NXP Semiconductors Group.

Basis of Presentation

The combined and consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

Predecessor period

The combined financial statements of the Company have been derived from the consolidated financial statements and accounting records of Philips prior to the Acquisition, principally using the historical results of operations and the historical basis of assets and liabilities of the semiconductor businesses. The combined financial statements include an allocation of the costs of certain corporate functions historically provided by Philips but not recorded by its semiconductors businesses. Additionally, the combined financial statements include allocated cash, debt and related interest income and expense, which have not been historically reported by Philips’ semiconductors businesses. Furthermore, the combined financial statements present income taxes calculated on a basis as if the Company had filed a separate income tax return.

The combined financial statements may not necessarily reflect the Company’s results of operations, financial position and cash flows in the future or what its results of operations, financial position and cash flows would have been, if the Company had been stand-alone during the predecessor periods.

Since a direct ownership relationship did not exist among the various worldwide entities comprising the Company prior to the legal separation from Philips, Philips’ net investments in the Company is shown as Business’ equity in lieu of Shareholder’s equity in the combined financial statements for the predecessor period.

Successor period

The consolidated financial statements include the accounts of NXP B.V. and its subsidiaries after the Acquisition. As a result of the purchase accounting applied to the Acquisition, the assets and liabilities reported in the consolidated balance sheet have changed substantially for the successor periods. Adjustments to the final purchase price paid by KASLION to Philips were made following the final settlement agreement reached between KASLION and Philips in the first quarter of 2007. The settlement of EUR 87 million was recorded in the first quarter. Payment is made in the second quarter of 2007.

3




Group performance

·                  all amounts in millions of euros unless otherwise stated; data included are unaudited

·                  financial reporting in accordance with US GAAP

·                  the impact on the 2007 financial results of the purchase price accounting used in connection with the Acquisition and the acquisition of the Silicon Labs’ cellular business under US GAAP (“purchase accounting”, or “PPA”) have been separately provided: financial results are also provided as adjusted to eliminate the impact of these accounting effects. This presentation does not comply with US GAAP, however the Company believes it provides investors with a useful basis of comparison with prior years’ results. Also the impact of cost allocations to the predecessor period and the actual stand-alone costs of the successor period have been described, where relevant to the analysis

·                  Earnings before Interest and Taxes (EBIT) as used by the Company, has the same meaning as income from operations as presented in the accompanying consolidated financial statements

Operational items

 

 

PREDECESSOR

 

 

 

 

 

SUCCESSOR

 

 

 

Q1
2006

 

Q1
2007

 

Effects of PPA

 

Q1 2007
excl. PPA

 

 

 

 

 

 

 

 

 

 

 

Sales

 

1,250

 

1,115

 

 

1,115

 

% nominal growth

 

20.0

 

(10.8

)

 

(10.8

)

% comparable growth

 

17.5

 

(2.7

)

 

(2.7

)

Gross margin

 

450

 

341

 

25

 

366

 

Selling expenses

 

(100

)

(86

)

 

(86

)

General and administrative expenses

 

(101

)

(211

)

120

 

(91

)

Research and development expenses

 

(232

)

(271

)

26

 

(245

)

Other income

 

4

 

5

 

 

5

 

Earnings before interest and tax (EBIT)

 

21

 

(222

)

171

 

(51

)

 

 

 

 

 

 

 

 

 

 

EBITA

 

15

 

(76

)

25

 

(51

)

EBITDA

 

173

 

85

 

 

85

 

Adjusted EBITA

 

71

 

(22

)

25

 

3

 

Adjusted EBITDA

 

229

 

139

 

 

139

 

Employees in FTE

 

35,472

 

37,620

 

 

37,620

 

 

Sales

Sales were EUR 1,115 million for the period January through March, 2007 (the reporting period), compared to EUR 1,250 million for the first quarter of 2006, a decrease of 10.8%. Excluding the effects of exited product lines and currency effects, the decrease was 2.7% on a comparable basis. Comparable sales reflect a comparison where sales are adjusted to eliminate the effect of changes in foreign currency exchange rates (a significant part of our sales is U.S. dollar-related and therefore impacted by currency movements) and exited product lines (mainly DVD-R, mobile display drivers and large display drivers businesses). Sales were strong in the Automotive & Identification business (10.1% comparable growth), while MultiMarket Semiconductors showed a 2.2% comparable growth. The other business units recorded a decrease compared to the first quarter of 2006. As a result of The continued industry slow down in the first quarter of 2007, sales performance was weak primarily caused by inventory corrections in the value chain.

Gross margin

Gross margin in the first quarter of 2007 was EUR 366 million, excluding the effects of purchase accounting, a decrease of EUR 84 million compared to EUR 450 million in the first quarter of 2006. As a percentage of

4




sales, gross margin decreased in the first quarter of 2007 to 32.8% from 36.0% in the first quarter of 2006.

The gross margin included restructuring and legal disentanglement costs which had a negative effect of EUR 29 million (compared to EUR 7 million in the corresponding period in 2006). Excluding these effects the gross margin percentage was slightly lower in the first quarter of 2007 compared to the corresponding period in 2006. This was mainly caused by reduced utilization of our manufacturing base (69% in the first quarter of 2007 versus 82% in the first quarter of 2006).

The financial impact of purchase accounting for the first quarter of 2007 was EUR 25 million and fully attributable to depreciation of tangible fixed assets.

Selling expenses

Selling expenses as a percentage of sales for the first quarter of 2007 were 7.7%, compared to 8.0% for the same period of 2006. The selling expenses in 2007 included EUR 8 million restructuring charges for sales offices and the centralization of customer service centers. In the corresponding period in 2006, EUR 11 million restructuring charges were included.

General and administrative expenses

General and administrative expenses (G&A), excluding the effects of purchase accounting, amounted to EUR 91 million (8.2% of sales) for the first quarter of 2007, compared to EUR 101 million (8.1% of sales) in the corresponding period of 2006.

G&A expenses include restructuring, legal disentanglement and similar cost items of EUR 12 million in 2007 (compared to EUR 10 million in 2006). The lower G&A costs are mainly attributable to reduced corporate infrastructure costs, partly offset by increased pension costs.

Purchase accounting effects in G&A for the first quarter of 2007 amounted to EUR 120 million and was related to amortization of intangible assets.

Research and development expenses

Research and development expenses (R&D), excluding the effects of purchase accounting, amounted to EUR 245 million (22.0% of sales) for the first quarter of 2007, compared to EUR 232 million (18.6% of sales) for the corresponding period in 2006. The investments in R&D resources, especially the increase in Automotive & Identification and corporate research activities, reflect the strategic focus on key competitive areas for the future. The increased investments were partly offset by reduced spending on exited product lines.

The R&D expenses include EUR 26 million write-off of acquired in-process R&D, related to the acquisition of the cellular business of Silicon Labs, in the first quarter of 2007.

Other income

For the first quarter 2007, other income was EUR 5 million, primarily consisting of the sale of various fixed assets. Other income was EUR 4 million for the corresponding period in 2006, mainly related to the sale of assets in the U.S.

Earnings before interest and taxes

Earnings before interest and taxes (EBIT) amounted to a loss of EUR 51 million in the first quarter of 2007, excluding the effects of purchase accounting of EUR 171 million, compared to a profit of EUR 21 million in the corresponding period of 2006. The lower EBIT was primarily caused by weaker sales and related reduced utilization of the manufacturing base.

Adjusted EBITA

5




Adjusted EBITA, excluding the effects of purchase accounting, for the first quarter of 2007 amounted to EUR 3 million, compared to EUR 71 million for the corresponding period in 2006. This decrease of EUR 68 million was mainly caused by lower EBIT in 2007.

Adjusted EBITDA

For the first quarter of 2007, adjusted EBITDA was EUR 139 million, compared to EUR 229 million in the same period last year. This decrease of EUR 90 million was mainly caused by lower EBIT in 2007.

The adjustments of EUR 54 million made to the first quarter EBITDA to arrive at adjusted EBITDA consist of:

·                  minority interests and results of unconsolidated companies of EUR 5 million

·                  restructuring costs of EUR 30 million and legal disentanglement related costs of EUR 11 million

·                  exit of product lines having no impact on a net basis, and

·                  other items of EUR 8 million (including Silicon Laboratories cellular business acquisition cost and a cross license settlement for previous years).

The corresponding EBITDA adjustments in the first quarter of 2006 totaled EUR 56 million, mainly consisting of results of unconsolidated companies and minority interests (EUR 18 million), restructuring charges (EUR 11 million), exit of product lines (EUR 11 million) and other items of EUR 16 million (related to legal disentanglement and litigation costs).

Net income

Net income

 

 

PREDECESSOR

 

SUCCESSOR

 

 

 

Q1
2006

 

Q1
2007

 

Effects of PPA

 

Q1 excl.
PPA 2007

 

 

 

 

 

 

 

 

 

 

 

Earnings before interest and tax

 

21

 

(222

)

171

 

(51

)

Financial income (expense)

 

(14

)

(70

)

 

(70

)

Income tax (expense) benefit

 

(6

)

31

 

(3

)

28

 

Result unconsolidated companies

 

 

 

 

 

Minority interest

 

(18

)

(5

)

 

(5

)

Net income (loss)

 

(17

)

(266

)

168

 

(98

)

 

Financial income and expense

Financial expenses amounted to EUR 70 million for the first quarter of 2007, consisting of net interest expenses of EUR 83 million, a charge for financing fees of EUR 6 million and the positive effect of exchange rates of EUR 19 million, mainly related to our USD denominated notes. Financial expense for the corresponding period in 2006 amounted to EUR 14 million, mainly consisting of the net interest expenses on funding provided by Philips.

Income tax (expense) benefit

For the first quarter 2007, the Company recognized an income tax benefit of EUR 28 million (excluding purchase accounting effects). For the first quarter of 2006 income tax expense amounted to EUR 6 million.

Minority interests

In the first quarter of 2007 the loss of EUR 5 million reflects the share of minority shareholders in consolidated companies. In the corresponding period of 2006, the loss was EUR 18 million. For both periods this was mainly related to the joint venture Systems on Silicon Manufacturing Company (SSMC).

6




Performance by segment

Mobile & Personal

Key data

 

Q1
2006

 

Q1
2007

 

Q1 2007
Excl. PPA

 

Sales

 

380

 

344

 

344

 

% nominal growth

 

9.2

 

(9.5

)

(9.5

)

% comparable growth

 

0.2

 

(1.1

)

(1.1

)

EBIT

 

3

 

(89

)

(19

)

EBITA

 

3

 

(21

)

(19

)

 

Sales were EUR 344 million for the first quarter 2007, compared to EUR 380 million for the corresponding period of 2006, a decrease of 9.5% (on a comparable basis a decrease of 1.1%) mainly driven by lower sales in the Connectivity and Cordless businesses.

EBIT in the first quarter of 2007 amounted to a loss of EUR 19 million, excluding the purchase accounting effects, compared to a profit of EUR 3 million in the corresponding period in 2006. The 2007 results include a restructuring charge for the Power Amplifiers/Front End Modules business of EUR 3 million. The decrease in EBIT was primarily caused by lower sales and lower yields associated with the ramp-up of the Power Management Units business.

On March 23, 2007 we consummated the acquisition of the Cellular Communications Business of Silicon Laboratories Inc. (as announced on February 8, 2007) for EUR 214 million in cash. NXP may pay up to an additional USD 65 million contingent upon the achievement of certain milestones in the next three years. The acquired cellular business of Silicon Labs was consolidated as from March 24, 2007 onwards and contributed EUR 1 million to sales.

Home

Key data

 

Q1
2006

 

Q1
2007

 

Q1 2007
Excl. PPA

 

 

 

 

 

 

 

 

 

Sales

 

242

 

175

 

175

 

% nominal growth

 

11.5

 

(27.7

)

(27.7

)

% comparable growth

 

15.2

 

(20.6

)

(20.6

)

EBIT

 

(8

)

(40

)

(19

)

EBITA

 

(8

)

(20

)

(19

)

 

Sales amounted to EUR 175 million for the first quarter of 2007, compared to EUR 242 million for the corresponding period in 2006, a decrease of 27.7%. On a comparable basis, sales decreased by 20.6%. The lower sales are primarily caused by the CRT TV-business, reflecting the ongoing market transition from analog to digital television technologies, and the exit from large display drivers and DVD-R activities.

EBIT in the first quarter of 2007 amounted to a loss of EUR 19 million, excluding the purchase accounting effects, compared to a loss of EUR 8 million in the same period last year. The unfavorable effect from the lower sales was partly offset by reduced R&D and SG&A costs.

7




 

Automotive & Identification

Key data

 

Q1
2006

 

Q1
2007

 

Q1 2007
Excl. PPA

 

Sales

 

218

 

230

 

230

 

% nominal growth

 

34.6

 

5.5

 

5.5

 

% comparable growth

 

29.0

 

10.1

 

10.1

 

EBIT

 

50

 

25

 

53

 

EBITA

 

50

 

52

 

53

 

 

Sales were EUR 230 million in the first quarter of 2007, compared with EUR 218 million for the corresponding period of 2006, an increase of 5.5%. On a comparable basis, sales increased by 10.1%, mainly driven by the Identification business.

EBIT in the first quarter of 2007 amounted to EUR 53 million, excluding the purchase accounting effects, an improvement of EUR 3 million compared to the corresponding period of 2006. This is attributable to an improvement in gross margin, partly offset by higher research and development investments.

MultiMarket Semiconductors

Key data

 

Q1
2006

 

Q1
2007

 

Q1 2007
Excl. PPA

 

 

 

 

 

 

 

 

 

Sales

 

345

 

319

 

319

 

% nominal growth

 

25.0

 

(7.5

)

(7.5

)

% comparable growth

 

30.5

 

2.2

 

2.2

 

EBIT

 

66

 

35

 

64

 

EBITA

 

66

 

61

 

64

 

 

Sales were EUR 319 million in the reporting period, compared to EUR 345 million in the same period of 2006, a decrease of 7.5% (comparable sales shows an increase of 2.2%). The nominal growth figure for the MultiMarket Semiconductors segment includes a significant impact resulting from our exit from the Mobile Display Drivers business, which has been eliminated in the comparable figure.

EBIT in the first quarter of 2007 amounted to EUR 64 million, excluding the purchase accounting effects, compared to a profit of EUR 66 million for the corresponding period in 2006.

IC Manufacturing Operations

Key data

 

Q1
2006

 

Q1
2007

 

Q1 2007
Excl. PPA

 

 

 

 

 

 

 

 

 

Sales 1)

 

49

 

32

 

32

 

% nominal growth

 

104.2

 

(34.7

)

(34.7

)

% comparable growth

 

87.3

 

(28.7

)

(28.7

)

EBIT

 

7

 

(74

)

(51

)

EBITA

 

7

 

(69

)

(51

)


1)    In the first quarter of 2007, IC Manufacturing Operations supplied EUR 396 million to other segments (first quarter of 2006:
EUR 510 million), which have been eliminated in the above presentation.

8




 

External sales decreased to EUR 32 million in the first quarter of 2007 from EUR 49 million in the corresponding period of 2006. This mainly reflects the lower sales of SSMC to TSMC.

EBIT in the first quarter of 2007 amounted to a loss of EUR 51 million, excluding purchase accounting effects, compared to a profit of EUR 7 million in the corresponding period in 2006. Excluding restructuring charges of EUR 19 million for the Nijmegen (the Netherlands) and Cabuyao (the Philippines) operations, EBIT for the first quarter of 2007 amounted to a loss of EUR 32 million. The lower EBIT was the result of decreased utilization rates from 82% in the first quarter of 2006 to 69% in the reporting period, partly offset by cost savings. EBIT included EUR 17 million costs related to the alliance in Crolles (France) in the reporting period (EUR 7 million in the corresponding period of 2006). The costs related to Crolles exclude R&D-related expenses which are reported under the Corporate and Other segment.

On March 22, 2007, the Company announced the closure of the Boeblingen operation in Germany and the reorganization of our back-end operations in the Philippines (Cabuyao). Restructuring charges, mainly related to the Boeblingen operations, are expected to be recorded during the remainder of the year 2007.

Corporate and Other

Key data

 

Q1
2006

 

Q1
2007

 

Q1 2007
Excl. PPA

 

 

 

 

 

 

 

 

 

Sales

 

16

 

15

 

15

 

% nominal growth

 

6.7

 

(6.3

)

(6.3

)

% comparable growth

 

(2.2

)

2.3

 

2.3

 

EBIT

 

(97

)

(79

)

(79

)

EBITA

 

(103

)

(79

)

(79

)

 

Sales in Corporate and Other are related to IP licensing income and software and totaled EUR 15 million for the reporting period, compared to EUR 16 million for the first quarter of 2006.

EBIT amounted to a loss of EUR 79 million for the first quarter of 2007 compared to a loss of EUR 97 million in the corresponding period of 2006. In the first quarter of 2007 costs of EUR 20 million were included for research activities, IP management and corporate infrastructure. For the corresponding period in 2006, during which the cost allocation methodology from Philips was applied, the related costs amounted to EUR 33 million.

EBIT in the first quarter of 2007 included EUR 11 million for R&D-related expenses in Crolles, similar to the EUR 11 million in the corresponding period in 2006.

On January 16, 2007, the Company announced that it would not extend its current cooperation in the Crolles alliance, beyond the initial term expiring at the end of 2007. NXP will work together with the alliance partners during the remainder of 2007 to complete the current program and effectively manage the transition.

Liquidity and Capital Resources

At the end of the first quarter of 2007, the cash position amounted to EUR 620 million, compared to EUR 939 million at December 31, 2006. Net cash used for operating activities was EUR 12 million, which included an increase in receivables related to the strong sales level at the end of the reporting period compared to the end of 2006. Furthermore, the acquisition of Silicon Labs cellular business amounted to EUR 214 million, and an amount of EUR 81 million was spent on capital expenditures.

9




 

Subsequent Events

On April 27, 2007, the Company launched an offer to exchange its outstanding Fixed and Floating Rate notes for identical notes registered under the U.S. Securities Act. The offers are expected to close on May 30, 2007 and will have no effect on the Company’s capitalization or debt outstanding.

Outlook

The market seems to have bottomed out although it remains weak. We see a short visibility of our orderbook reflecting the current volatility in the industry. Given our book-to-bill ratio of 1.03 in the first quarter, we expect flat to low single-digit sequential sales growth for the second quarter 2007 on a currency comparable basis. We believe we are well positioned to benefit from a next upturn in the relevant semiconductor market segments.

10




Combined and Consolidated
statements of operations

all amounts in millions of euros

 

 

PREDECESSOR

 

SUCCESSOR

 

 

 

January to March

 

 

 

2006

 

2007

 

Sales

 

1,219

 

1,101

 

Sales to Philips companies

 

31

 

14

 

Total sales

 

1,250

 

1,115

 

 

 

 

 

 

 

Cost of sales

 

(800

)

(774

)

 

 

 

 

 

 

Gross margin

 

450

 

341

 

 

 

 

 

 

 

Selling expenses

 

(100

)

(86

)

General and administrative expenses

 

(101

)

(211

)

Research and development expenses

 

(232

)

(245

)

Write-off of acquired in-process research and development

 

 

(26

)

Other income (expense)

 

4

 

5

 

 

 

 

 

 

 

Income (loss) from operations

 

21

 

(222

)

 

 

 

 

 

 

Financial income (expense)

 

(14

)

(70

)

 

 

 

 

 

 

Income (loss) before taxes

 

7

 

(292

)

 

 

 

 

 

 

Income tax (expense) benefit

 

(6

)

31

 

 

 

 

 

 

 

Income (loss) after taxes

 

1

 

(261

)

 

 

 

 

 

 

Results relating to unconsolidated companies

 

 

 

 

 

 

 

 

 

Minority interests

 

(18

)

(5

)

 

 

 

 

 

 

Net income (loss)

 

(17

)

(266

)

 

 

 

 

 

 

 

11




Combined and Consolidated
balance sheets

all amounts in millions of euros

 

 

PREDECESSOR

 

SUCCESSOR

 

 

 

March 31,
2006

 

December 31,
 2006

 

March 31,
2007

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

97

 

939

 

620

 

Receivables

 

569

 

563

 

591

 

Inventories

 

708

 

646

 

641

 

Other current assets

 

20

 

125

 

117

 

Total current assets

 

1,394

 

2,273

 

1,969

 

 

 

 

 

 

 

 

 

Non-current assets:

 

 

 

 

 

 

 

Investments in unconsolidated companies

 

48

 

44

 

45

 

Other non-current financial assets

 

7

 

12

 

12

 

Other non-current assets

 

151

 

157

 

216

 

Property, plant and equipment

 

1,995

 

2,284

 

2,190

 

Intangible assets excluding goodwill

 

54

 

3,065

 

3,055

 

Goodwill

 

210

 

2,032

 

2,162

 

Total non-current assets

 

2,465

 

7,594

 

7,680

 

 

 

 

 

 

 

 

 

Total assets

 

3,859

 

9,867

 

9,649

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts and notes payable

 

479

 

489

 

458

 

Accrued liabilities

 

533

 

485

 

537

 

Short-term provisions

 

34

 

54

 

57

 

Other current liabilities

 

57

 

45

 

136

 

Short-term debt

 

166

 

23

 

16

 

Loans with Philips companies, current portion

 

217

 

 

 

Total current liabilities

 

1,486

 

1,096

 

1,204

 

 

 

 

 

 

 

 

 

Non-current liabilities:

 

 

 

 

 

 

 

Long-term debt

 

142

 

4,426

 

4,397

 

Loans with Philips companies, non-current portion

 

315

 

 

 

Long-term provisions

 

51

 

368

 

385

 

Other non-current liabilities

 

7

 

130

 

98

 

Total non-current liabilities

 

515

 

4,924

 

4,880

 

 

 

 

 

 

 

 

 

Minority interests

 

188

 

162

 

162

 

Business’ equity

 

1,670

 

 

 

Shareholder’s equity

 

 

3,685

 

3,403

 

 

 

 

 

 

 

 

 

Total liabilities and equity

 

3,859

 

9,867

 

9,649

 

 

 

 

 

 

 

 

 

 

12




Combined and Consolidated
statements of cash flows

all amounts in millions of euros

 

 

 

PREDECESSOR

 

SUCCESSOR

 

 

 

January to March

 

 

 

2006

 

2007

 

Cash flows from operating activities:

 

 

 

 

 

Net income (loss)

 

(17

)

(266

)

Adjustments to reconcile net income (loss) to net cash provided byoperating activities:

 

 

 

 

 

Depreciation and amortization

 

170

 

312

 

Net gain on sale of assets

 

(1

)

(1

)

Results relating to unconsolidated companies

 

 

 

Minority interests (net of dividends paid to minority shareholders)

 

18

 

3

 

Decrease (increase) in receivables and other current assets

 

110

 

(25

)

Decrease (increase) in inventories

 

(22

)

15

 

Increase (decrease) in accounts payable, accrued and other liabilities

 

39

 

1

 

Decrease (increase) in current accounts Philips

 

(46

)

 

Decrease (increase) in non-current receivables/other assets

 

48

 

(59

)

Increase (decrease) in provisions

 

(35

)

27

 

Other items

 

4

 

(19

)

Net cash provided by (used for) operating activities

 

268

 

(12

)

Cash flows from investing activities:

 

 

 

 

 

Purchase of intangible assets

 

(4

)

(3

)

Capital expenditures on property, plant and equipment

 

(126

)

(81

)

Proceeds from disposals of property, plant and equipment

 

6

 

8

 

Purchase of other non-current financial assets

 

 

 

Purchase of interest in businesses

 

 

(215

)

Proceeds from sale of interests in businesses

 

 

 

Net cash provided by (used for) investing activities

 

(124

)

(291

)

Cash flows from financing activities:

 

 

 

 

 

PREDECESSOR

 

 

 

 

 

(Decrease) increase in debt

 

(63

)

 

 

Net repayments of loans to Philips companies

 

(581

)

 

 

Net changes in Business’ equity

 

490

 

 

 

SUCCESSOR

 

 

 

 

 

(Decrease) increase in debt

 

 

 

(7

)

Net cash provided by (used for) financing activities

 

(154

)

(7

)

Effect of changes in exchange rates on cash positions

 

(3

)

(9

)

Increase (decrease) in cash and cash equivalents

 

(13

)

(319

)

Cash and cash equivalents at beginning of period

 

110

 

939

 

Cash and cash equivalents at end of period

 

97

 

620

 

 

13




 

Consolidated statements of changes in
shareholder’s equity and comprehensive income (loss)

all amounts in millions of euros

 

 

 

 


SUCCESSOR

 

 

 

January to March 2007

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive income (loss)

 

 

 

 

 

Common
stock

 

Capital in
excess
of par
value

 

Retained
earnings

 

Currency
translation
differences

 

Changes in
fair value
of cash
flow
hedges

 

Total

 

Total share-
holder’s
 equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2006

 

 

4,305

 

(616

)

(10

)

6

 

(4

)

3,685

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

 

(266

)

 

 

 

 

 

 

 

 

(266

)

Current period change

 

 

 

 

 

 

 

(15

)

1

 

(14

)

(14

)

Reclassifications into income (loss)

 

 

 

 

 

 

 

 

 

(2

)

(2

)

(2

)

Income tax on current period change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive income, net of tax

 

 

 

 

 

(266

)

(15

)

(1

)

(16

)

(282

)

Balance as of March 31, 2007

 

 

4,305

 

(882

)

(25

)

5

 

(20

)

3,403

 

 

14




Information by segments

 

all amounts in millions of euros unless otherwise stated

Sales, R&D expenses and income from operations

 

 

PREDECESSOR

 

SUCCESSOR

 

 

 

January to March

 

 

 

2006

 

2007

 

 

 

Sales

 

Research
and
development
expenses

 

Income (loss)
from operations

 

Sales

 

Research
and
development
expenses

 

Income (loss)
from operations

 

 

 

 

 

 

 

amount

 

as a% of
sales

 

 

 

 

 

amount

 

as a% of
sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mobile & Personal

 

380

 

92

 

3

 

0.8

 

344

 

93

 

(89

)

(25.9

)

Home

 

242

 

49

 

(8

)

(3.3

)

175

 

44

 

(40

)

(22.9

)

Automotive & Identification

 

218

 

28

 

50

 

22.9

 

230

 

35

 

25

 

10.9

 

MultiMarket Semiconductors

 

345

 

21

 

66

 

19.1

 

319

 

22

 

35

 

11.0

 

IC Manufacturing Operations

 

49

(2)

9

 

7

 

14.3

 

32

(2)

8

 

(74

)

(1)

Corporate and Other

 

16

 

33

 

(97

)

(1)

15

 

43

 

(79

)

(1)

 

 

1,250

 

232

 

21

 

1.7

 

1,115

 

245

 

(222

)

(19.9

)


(1)             Not meaningful

(2)             In the first quarter of 2007, IC Manufacturing Operations supplied EUR 396 million to other segments   (first quarter of 2006: EUR 510 million), which have been eliminated in the above presentation.

 

 

15




Main countries

 

all amounts in millions of euros

Sales

 

 

PREDECESSOR

 

SUCCESSOR

 

 

 

January to March

 

 

 

2006

 

2007

 

 

 

 

 

 

 

China

 

367

 

202

 

Netherlands

 

216

 

200

 

Taiwan

 

101

 

86

 

United States

 

135

 

101

 

Singapore

 

142

 

191

 

Germany

 

66

 

73

 

South Korea

 

9

 

11

 

Other Countries

 

214

 

251

 

 

 

1,250

 

1,115

 

 

16




 

Reconciliation of non-US GAAP
information

all amounts in millions of euros unless otherwise stated

Certain non-US GAAP financial measures are presented when discussing the NXP Group’s financial position. In the following tables, a reconciliation to the most directly comparable US GAAP financial measure is made for each non-US GAAP performance measure.

Sales growth composition (in %)

 

 

Comparable
growth

 

Currency
effects

 

Exit of
product lines

 

Nominal
growth

 

Q1 2007 versus Q1 2006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mobile & Personal

 

(1.1

)

(7.0

)

(1.4

)

(9.5

)

Home

 

(20.6

)

(5.6

)

(1.5

)

(27.7

)

Automotive & Identification

 

10.1

 

(4.6

)

 

5.5

 

MultiMarket Semiconductors

 

2.2

 

(5.9

)

(3.8

)

(7.5

)

IC Manufacturing Operations

 

(28.7

)

(6.0

)

 

(34.7

)

Corporate and Other

 

2.3

 

(8.6

)

 

(6.3

)

 

 

 

 

 

 

 

 

 

 

NXP Group

 

(2.7

)

(6.1

)

(2.0

)

(10.8

)

 

 

 

Comparable
growth

 

Currency
effects

 

Exit of
product lines

 

Nominal
growth

 

Q1 2006 versus Q1 2005

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mobile & Personal

 

0.2

 

7.5

 

1.5

 

9.2

 

Home

 

15.2

 

8.7

 

(12.4

)

11.5

 

Automotive & Identification

 

29.0

 

5.6

 

 

34.6

 

MultiMarket Semiconductors

 

30.5

 

8.0

 

(13.5

)

25.0

 

IC Manufacturing Operations

 

87.3

 

16.9

 

 

104.2

 

Corporate and Other

 

(2.2

)

8.9

 

 

6.7

 

 

 

 

 

 

 

 

 

 

 

NXP Group

 

17.5

 

7.8

 

(5.3

)

20.0

 

 

Adjusted EBITA to EBITA to Net income (loss)

 

 

 

Q1
2006

 

Q1
2007

 

 

 

 

 

 

 

Adjusted EBITA

 

71

 

3

 

Add back:

 

 

 

 

 

Exit of product lines

 

(11

)

 

Restructuring costs and impairment

 

(11

)

(30

)

Minority interest and results of unconsolidated companies

 

(18

)

(5

)

Other

 

(16

)

(19

)

Effects of PPA (only relates to depreciation property, plant and equipment

 

 

(25

)

 

 

 

 

 

 

EBITA

 

15

 

(76

)

 

 

 

 

 

 

Include:

 

 

 

 

 

 

 

 

 

 

 

Amortization intangible assets

 

(12

)

(151

)

Financial income (expenses)

 

(14

)

(70

)

Income tax (expense) benefit

 

(6

)

31

 

 

 

 

 

 

 

Net income (loss)

 

(17

)

(266

)

 

17




 

Reconciliation of non-US GAAP
information (continued)

Adjusted EBITDA to EBITDA to Net income (loss)

 

 

Q1
2006

 

Q1
2007

 

 

 

 

 

 

 

Adjusted EBITDA

 

229

 

139

 

Add back:

 

 

 

 

 

Exit of product lines

 

(11

)

 

Restructuring costs and impairment

 

(11

)

(30

)

Minority interest and results of unconsolidated companies

 

(18

)

(5

)

Other

 

(16

)

(19

)

Effects of PPA

 

 

 

 

 

 

 

 

 

EBITDA

 

173

 

85

 

 

 

 

 

 

 

Include:

 

 

 

 

 

Amortization intangible assets

 

(12

)

(151

)

Depreciation property, plant and equipment

 

(158

)

(161

)

Financial income (expenses)

 

(14

)

(70

)

Income tax (expense) benefit

 

(6

)

31

 

 

 

 

 

 

 

Net income (loss)

 

(17

)

(266

)

 

EBITA to EBIT

 

 

 

NXP
Group

 

Mobile &
Personal

 

Home

 

Automotive &
Identification

 

MultiMarket
Semiconductors

 

IC
Manufacturing
Operations

 

Corporate 
and Other

 

Q1 2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITA

 

(76

)

(21

)

(20

)

52

 

61

 

(69

)

(79

)

Amortization intangible assets

 

(151

)

(68

)

(20

)

(27

)

(26

)

(5

)

(5

)

Minority interest and results of unconsolidated companies

 

5

 

 

 

 

 

 

5

 

EBIT

 

(227

)

(89

)

(40

)

25

 

35

 

(74

)

(79

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Q1 2006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITA

 

15

 

3

 

(8

)

50

 

66

 

7

 

(103

)

Amortization intangible assets

 

(12

)

 

 

 

 

 

 

(12

)

Minority interest and results of unconsolidated companies

 

18

 

 

 

 

 

 

18

 

EBIT

 

21

 

3

 

(8

)

50

 

66

 

7

 

(97

)

 

Composition of net debt to group equity

 

 

 

Full year
2006

 

Q1
2007

 

 

 

 

 

 

 

Long-term debt

 

4,426

 

4,397

 

Short-term debt

 

23

 

16

 

Total debt

 

4,449

 

4,413

 

Cash and cash equivalents

 

(939

)

(620

)

Net debt (total debt less cash and cash equivalents)

 

3,510

 

3,793

 

 

 

 

 

 

 

Minority interests

 

162

 

162

 

Shareholder’s equity

 

3,685

 

3,403

 

Group equity

 

3,847

 

3,565

 

 

 

 

 

 

 

Net debt and group equity

 

7,357

 

7,358

 

Net debt divided by net debt and group equity (in %)

 

48

 

52

 

Group equity divided by net debt and group equity (in %)

 

52

 

48

 

 

18




 

Supplemental consolidated statement of
operations for the period January to March, 2007

 

all amounts in millions of euros

 

 

NXP
B.V.

 

guarantors

 

non-
guarantors

 

eliminations/
reclassifications

 

consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

 

815

 

300

 

 

1,115

 

Intercompany sales

 

 

249

 

120

 

(369

)

 

Total sales

 

 

1,064

 

420

 

(369

)

1,115

 

Cost of sales

 

(25

)

(701

)

(405

)

357

 

(774

)

Gross margin

 

(25

)

363

 

15

 

(12

)

341

 

Selling expenses

 

 

(66

)

(21

)

1

 

(86

)

General and administrative expenses

 

(120

)

(77

)

(14

)

 

(211

)

Research and development expenses

 

 

(156

)

(100

)

11

 

(245

)

Write-off of acquired in-process research and development

 

(26

)

 

 

 

(26

)

Other income (loss)

 

(15

)

(101

)

121

 

 

5

 

Income (loss) from operations

 

(186

)

(37

)

1

 

 

(222

)

Financial expense

 

(24

)

(42

)

(4

)

 

(70

)

Income (loss) before taxes

 

(210

)

(79

)

(3

)

 

(292

)

Income tax (expense) benefit

 

3

 

32

 

(4

)

 

31

 

Income (loss) after taxes

 

(207

)

(47

)

(7

)

 

(261

)

Income subsidiaries

 

(59

)

 

 

59

 

 

Results relating to unconsolidated companies

 

 

 

 

 

 

Minority interests

 

 

 

(5

)

 

(5

)

Net income (loss)

 

(266

)

(47

)

(12

)

59

 

(266

)

 

 

19




Supplemental consolidated balance sheet at March 31, 2007

all amounts in millions of euros

 

 

NXP B.V.

 

guarantors

 

non-
guarantors

 

eliminations/
reclassifications

 

consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

271

 

148

 

201

 

 

620

 

Receivables

 

 

393

 

198

 

 

591

 

Intercompany accounts receivable

 

128

 

611

 

139

 

(878

)

 

Inventories

 

8

 

553

 

80

 

 

641

 

Other current assets

 

3

 

64

 

50

 

 

117

 

Total current assets

 

410

 

1,769

 

668

 

(878

)

1,969

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets:

 

 

 

 

 

 

 

 

 

 

 

Investments in unconsolidated companies

 

43

 

1

 

1

 

 

45

 

Investments in affiliated companies

 

2,170

 

 

 

(2,170

)

 

Other non-current financial assets

 

 

8

 

4

 

 

12

 

Other non-current assets

 

78

 

124

 

14

 

 

216

 

Property, plant and equipment

 

369

 

1,092

 

729

 

 

2,190

 

Intangible assets excluding goodwill

 

3,006

 

42

 

7

 

 

3,055

 

Goodwill

 

2,162

 

 

 

 

2,162

 

Total non-current assets

 

7,818

 

1,267

 

755

 

(2,170

)

7,680

 

Total assets

 

8,238

 

3,036

 

1,423

 

(3,048

)

9,649

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Shareholder’s equity

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

Accounts and notes payable

 

 

359

 

99

 

 

458

 

Intercompany accounts payable

 

6

 

641

 

231

 

(878

)

 

Accrued liabilities

 

123

 

263

 

151

 

 

537

 

Short-term provisions

 

(1

)

41

 

17

 

 

57

 

Other current liabilities

 

82

 

35

 

19

 

 

136

 

Short-term debt

 

 

 

16

 

 

16

 

Intercompany financing

 

 

2,881

 

284

 

(3,165

)

 

Total current liabilities

 

210

 

4,220

 

817

 

(4,043

)

1,204

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current liabilities:

 

 

 

 

 

 

 

 

 

 

 

Long-term debt

 

4,386

 

4

 

7

 

 

4,397

 

Long-term provisions

 

239

 

140

 

6

 

 

385

 

Other non-current liabilities

 

 

84

 

14

 

 

98

 

Total non-current liabilities

 

4,625

 

228

 

27

 

 

4,880

 

Minority interests

 

 

 

162

 

 

162

 

Shareholder’s equity

 

3,403

 

(1,412

)

417

 

995

 

3,403

 

Total liabilities and Shareholder’s equity

 

8,238

 

3,036

 

1,423

 

(3,048

)

9,649

 

 

20




Supplemental consolidated statement of
cash flows for the period January to March, 2007

all amounts in millions of euros

 

 

NXP
B.V.

 

guarantors

 

non-guarantors

 

eliminations

 

consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

(266

)

(47

)

(12

)

59

 

(266

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

Elimination (income) loss subsidiaries

 

59

 

 

 

(59

)

 

Depreciation and amortization

 

171

 

78

 

63

 

 

312

 

Net gain on sale of assets

 

 

(1

)

 

 

(1

)

Results relating to unconsolidated companies

 

 

 

 

 

 

Minority interests (net of dividends paid to minority shareholders)

 

 

 

3

 

 

3

 

Decrease (increase) in receivables and other currentassets

 

17

 

(39

)

(3

)

 

(25

)

Decrease (increase) in inventories

 

(4

)

22

 

(3

)

 

15

 

Increase (decrease) in accounts payable, accrued andother liabilities

 

36

 

(36

)

1

 

 

1

 

Decrease (increase) intercompany current accounts

 

(231

)

166

 

65

 

 

 

Decrease (increase) in non-current receivables/other assets

 

(7

)

(46

)

(6

)

 

(59

)

Increase (decrease) in provisions

 

(2

)

30

 

(1

)

 

27

 

Other items

 

(22

)

3

 

 

 

(19

)

Net cash provided by (used for) operating activities

 

(249

)

130

 

107

 

 

(12

)

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

Purchase of intangible assets

 

 

(2

)

(1

)

 

(3

)

Capital expenditures on property, plant and equipment

 

 

(39

)

(42

)

 

(81

)

Proceeds from disposals of property, plant andequipment

 

 

7

 

1

 

 

8

 

Purchase of other non-current financial assets

 

 

 

 

 

 

Purchase of interest in businesses

 

(214

)

 

(1

)

 

(215

)

Proceeds from sale of interests in unconsolidated businesses

 

 

 

 

 

 

Net cash provided by (used for) investing activities

 

(214

)

(34

)

(43

)

 

(291

)

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

(Decrease) increase in debt

 

(1

)

 

(6

)

 

(7

)

Net changes in intercompany financing

 

121

 

(80

)

(41

)

 

 

Net changes in intercompany equity

 

5

 

(27

)

22

 

 

 

Net cash provided by (used for) financing activities

 

125

 

(107

)

(25

)

 

(7

)

Effect of changes in exchange rates on cash positions

 

(4

)

(2

)

(3

)

 

(9

)

Increase (decrease) in cash and cash equivalents

 

(342

)

(13

)

36

 

 

(319

)

Cash and cash equivalents at beginning of period

 

613

 

161

 

165

 

 

939

 

Cash and cash equivalents at end of period

 

271

 

148

 

201

 

 

620

 

 

21




Quarterly statistics

all amounts in millions of euros unless otherwise stated

 

 

PREDECESSOR

 

 

 

SUCCESSOR

 

 

 

 

 

 

 

 

 

 

 

2006

 

 

 

 

 

 

 

2007

 

 

 

1st quarter

 

2nd quarter

 

3rd quarter

 

 

 

4th quarter

 

1st quarter

 

2nd quarter

 

3rd quarter

 

4th quarter

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

1,250

 

1,238

 

1,282

 

 

 

1,190

 

1,115

 

 

 

 

 

 

 

% increase

 

19.8

 

9.5

 

3.9

 

 

 

(12.4

)

(10.8

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

21

 

52

 

66

 

 

 

(779

)

(222

)

 

 

 

 

 

 

as a % of sales

 

1.7

 

4.2

 

5.1

 

 

 

(65.5

)

(19.9

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITA

 

15

 

40

 

56

 

 

 

(145

)

(76

)

 

 

 

 

 

 

as a % of sales

 

1.2

 

3.2

 

4.4

 

 

 

(12.2

)

(6.8

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

173

 

187

 

203

 

 

 

26

 

85

 

 

 

 

 

 

 

as a % of sales

 

13.8

 

15.1

 

15.8

 

 

 

2.2

 

7.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITA

 

71

 

64

 

120

 

 

 

69

 

3

 

 

 

 

 

 

 

as a % of sales

 

5.7

 

5.2

 

9.4

 

 

 

5.8

 

0.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

229

 

211

 

267

 

 

 

214

 

139

 

 

 

 

 

 

 

as a % of sales

 

18.3

 

17.0

 

20.8

 

 

 

18.0

 

12.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

(17

)

(5

)

27

 

 

 

(616

)

(266

)

 

 

 

 

 

 

 

 

 

January-
March

 

January-
June

 

January-
September

 

 

 

January-
December

 

January-
March

 

January-
June

 

January-
September

 

January-
December

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

1,250

 

2,488

 

3,770

 

 

 

4,960

 

1,115

 

 

 

 

 

 

 

% increase

 

19.8

 

14.4

 

10.6

 

 

 

4.1

 

(10.8

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

21

 

73

 

139

 

 

 

(640

)

(222

)

 

 

 

 

 

 

as a % of sales

 

1.7

 

2.9

 

3.7

 

 

 

(12.9

)

(19.9

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITA

 

15

 

55

 

111

 

 

 

(34

)

(76

)

 

 

 

 

 

 

as a % of sales

 

1.2

 

2.2

 

2.9

 

 

 

(0.7

)

(6.8

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

173

 

360

 

563

 

 

 

589

 

85

 

 

 

 

 

 

 

as a % of sales

 

13.8

 

14.5

 

14.9

 

 

 

11.9

 

7.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITA

 

71

 

135

 

255

 

 

 

324

 

3

 

 

 

 

 

 

 

as a % of sales

 

5.7

 

5.4

 

6.8

 

 

 

6.5

 

0.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

229

 

440

 

707

 

 

 

921

 

139

 

 

 

 

 

 

 

as a % of sales

 

18.3

 

17.7

 

18.8

 

 

 

18.6

 

12.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

(17

)

(22

)

5

 

 

 

(611

)

(266

)

 

 

 

 

 

 

 

 

 

 

 

 

 

period ending 2006

 

Period ending 2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventories as a % of sales

 

14.3

 

14.0

 

13.8

 

13.0

 

13.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net debt: group equity ratio

 

—(1)

 

—(1)

 

—(1)

 

48:52

 

52:48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employees (in FTE)

 

35,472

 

36,996

 

38,144

 

37,468

 

37,620

 

 

 

 

 

 

 


(1)             Not meaningful

 

22



Exhibit 99.2

NXP announces launch of exchange offer for its Notes

Eindhoven, The Netherlands — NXP B.V. (“NXP”) announced today the launch of offers to exchange (the “Exchange Offers”) up to  €1,000,000,000 principal amount Floating Rate Senior Secured Notes due 2013,  $1,535,000,000 principal amount Floating Rate Senior Secured Notes due 2013,  $1,026,000,000 principal amount 7 7/8% Senior Secured Notes due 2014, €525,000,000 principal amount 8 5/8% Senior Notes due 2015 and $1,250,000,000 principal amount 9 1/2% Senior Notes due 2015 (the “Exchange Notes”) for any and all of its outstanding euro-denominated Floating Rate Senior Secured Notes, dollar-denominated Floating Rate Senior Secured Notes, dollar denominated 7 7/8% Senior Secured Notes, euro-denominated  8 5/8% Senior Notes and dollar-denominated 9 ½% Senior Notes  (the “Existing Notes”). The Exchange Notes are identical in all material respects to the Existing Notes, except that the Exchange Notes have been registered with the U.S. Securities and Exchange Commission (the “SEC”) under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and are not subject to the transfer restrictions and registration rights relating to the Existing Notes. The Exchange Notes will be guaranteed on a senior basis by certain of our current and future material wholly-owned subsidiaries.

The exchange offers for dollar-denominated outstanding notes expire at 5:00 PM (New York City time) on May 30, 2007, unless extended. The exchange offers for euro-denominated outstanding notes expire at 5:00 PM (London time) on May 30, 2007, unless extended. The Exchange Offers are not conditioned upon any minimum principal amount of Existing Notes being tendered for exchange. Any Existing Notes not tendered will remain subject to existing transfer restrictions.

The Existing Notes were sold to institutional investors in a private placement on October 12, 2006, at which time NXP agreed to file a registration statement with the SEC for the Exchange Offers prior to January 5, 2008. The SEC declared the registration statement relating to the Exchange Offers effective on April 26, 2007. NXP expects the Exchange Notes to be accepted for clearance through Euroclear and Clearstream or DTC, as applicable, with the following CUSIP / common codes and international securities identification numbers:

 

Exchange Notes

 

CUSIP

 

Common Code

 

ISIN

EUR Floating Rate Senior Secured Notes due 2013

 

 

 

029843643

 

XS0298436436

USD Floating Rate Senior Secured Notes due 2013

 

62947Q AE8

 

 

 

US62947QAE89

USD 7⅞% Senior Secured Notes due 2014

 

62947Q AF5

 

 

 

US62947QAF54

EUR 8⅝% Senior Notes due 2015

 

 

 

029843708

 

XS0298437087

EUR 9½% Senior Notes due 2015

 

62947Q AG3

 

 

 

US62947QAG38

 

The Existing Notes are listed on the Alternative Securities Market of the Irish Stock Exchange (SEDOL B1FSGX0 for the euro-denominated Floating rate Senior Secured Notes due 2013; SEDOL B1FSJG4 for the dollar-denominated Floating rate Senior Secured Notes due 2013; SEDOL B1FSDN9 for the dollar-denominated 7 7/8% Senior Secured Notes due 2014; SEDOL B1FSJ53 for the euro-denominated 8 5/8% Senior Notes due 2015 and SEDOL B1FSJK8 for the dollar-denominated 9 ½ %




Senior Notes due 2015).Application has been made for the Exchange Notes to be listed on the Alternative Securities Market of the Irish Stock Exchange.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any Exchange Notes or any other security and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful.

Contact
NXP B.V.
Investor Relations

High Tech Campus 60
5656 AG Eindhoven
The Netherlands

Jan Maarten Ingen Housz
+31 40 27 22315
Contact

Media
Sander Arts
+31 40 27 25159
Contact

About NXP
NXP is a top 10 semiconductor company founded by Philips more than 50 years ago. Headquartered in Europe, the company has 37,000 employees working in 26 countries across the world. NXP creates semiconductors, system solutions and software that deliver better sensory experiences in mobile phones, personal media players, TVs, set-top boxes, identification applications, cars and a wide range of other electronic devices. News from NXP is located at www.nxp.com.

Forward-looking Statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of NXP and certain plans and objectives of NXP with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

 



Exhibit 99.3

NXP Semiconductors Announces First Quarter 2007 Results

Highlights

·                  First quarter sales at EUR 1,115 million

·                  Sales growth quarter-on-quarter -4.4% (currency comparable)

·                  First quarter adjusted EBITA excluding effects of Purchase Accounting at EUR 3 million

·                  Successful closing of the Silicon Labs acquisition

·                  Cash position of EUR 620 million after the acquisition of the cellular business of Silicon Labs

·                  Forceful continuation of the Business Renewal Strategy

Eindhoven, The Netherlands, May 3 2007 — NXP Semiconductors today announced its first quarter 2007 results. Sales for the quarter amounted to EUR 1,115 million, a year-on-year decrease of 2.7% on a currency comparable basis and — 10.8% on a nominal basis. The sequential decrease was 6.3% (excluding currency effects - 4.4%). Excluding the impact of Purchase Accounting, adjusted EBITA was a profit of EUR 3 million, compared to a profit of EUR 71 million in the first quarter of 2006. The full report is available on NXP website (www.nxp.com/investor).

Frans van Houten, President and CEO of NXP Semiconductors, commented, “The market remained challenging in the first quarter, especially for our Home and Mobile and Personal businesses. Sound performance continues to be shown by our Multimarket, Automotive and Identification businesses. We continue to aggressively position ourselves for the next industry upturn by forcefully executing on our Business Renewal strategy. We announced the closure of the Böblingen facility, consolidation of our Philippines industrial operations, and the completion of the acquisition of the Silicon Labs cellular business. In addition, we have won important new customers in our key growth businesses.”

Our book to bill ratio was 1.03 in the first quarter. The factory utilisation was 69%.

Outlook: The market remains weak and seems to have bottomed out. Due to the short visibility of the order book, reflecting the current volatility in the industry, we expect flat to low single digit sales growth in the second quarter.

About NXP Semiconductors
NXP is a top semiconductor company founded by Philips more than 50 years ago. Headquartered in Europe, the company has 37,000 employees working in more than 20 countries and posted sales of EUR 5 billion in 2006. NXP creates semiconductors, system solutions and software that deliver better sensory experiences in mobile phones, personal media players, TVs, set-top boxes, identification applications, cars and a wide range of other electronic devices. News from NXP is located at www.nxp.com.

CONTACT:

Investors:
Jan Maarten Ingen Housz, +31 40 27 22315
janmaarten.ingen.housz@nxp.com

Media:
Sander Arts, +31 40 27 25159
Sander.arts@nxp.com